Company intelligence / Profile preview
Dandu Biosciences
- Ownership
- Private
- Employees
- ~75
- Development stage
- Preclinical
Overview
Dandu Biosciences is a Hyderabad-based biotech company focused on developing and manufacturing biosimilars and complex generic pharmaceuticals, aiming to provide affordable medications globally. Their portfolio includes at least one key product, Liraglutide, but no detailed clinical results or approvals are publicly available as of the latest updates.
- Therapeutic areas
- Endocrinology
- Modalities
- BiosimilarsComplex generics
- Industry
- Biotech
Drug pipeline
2 assets1 more asset in the full pipeline.
Request access →Beyond the preview
Go deeper on Dandu Biosciences.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Dandu Biosciences.